![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Moderna May Supply Up to 160 Million COVID-19 Vaccine Doses to EU
Moderna May Supply Up to 160 Million COVID-19 Vaccine Doses to EU
![Moderna logo](https://www.fdanews.com/ext/resources/test/Drug-Images4/Moderna-logo.jpg?t=1589311392&width=430)
August 25, 2020
Moderna announced that it has concluded exploratory talks with the European Commission for a deal to supply up to 160 million doses of its COVID-19 vaccine.
The commission is expected to purchase 80 million doses of Moderna’s mRNA-1273 vaccine candidate and has an option to purchase an additional 80 million doses. Swiss manufacturer Lonza and Spain-based ROVI will manufacture the vaccine for Europe.
Moderna began phase 3 testing of vaccine candidate mRNA-1273 in July and is on track to complete enrollment of 30,000 patients in September.
Upcoming Events
-
21Oct